Smart sensors could revolutionize ICU blood sugar management

NCT ID NCT05585801

Ongoing Disease control Sponsor: Institute for Clinical and Experimental Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether continuous glucose monitors (CGMs) can help ICU patients maintain safe blood sugar levels more effectively than standard finger-stick checks. Researchers will enroll 500 adults undergoing major surgeries like pancreas or liver transplants. The goal is to see if CGMs reduce time spent outside the target glucose range and ease the workload on nurses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexcom G6 continuous glucose monitor
What this could lead to: If successful, this could show that continuous glucose monitors are reliable and effective for managing blood sugar in ICU patients, potentially becoming a new standard of care.
What could go wrong: This is a single-center study with 500 patients, and results may not apply to all ICU settings. The device's accuracy in critically ill patients is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD GLUCOSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD GLUCOSE CRITICAL CARE

Contacts and locations

Locations

Institute for Clinical and Experimental Medicine

Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.